Related Experiment Video
Updated: Jul 8, 2026

08:42
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Model systems for studying skeletal dysplasias caused by TSP-5/COMP mutations
K L Posey1, Y Yang, A C Veerisetty
1Department of Pediatrics, University of Texas Medical School at Houston, 6431 Fannin, Houston, Texas 77030, USA.
Cellular and Molecular Life Sciences : CMLS
|January 15, 2008
Summary
Mutations in cartilage oligomeric matrix protein (TSP-5) cause skeletal dysplasias like pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED). Model systems reveal TSP-5 pathology involves unfolded protein response, apoptosis, and matrix misassembly in chondrocytes.
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- Cartilage oligomeric matrix protein (TSP-5) is crucial for cartilage and musculoskeletal tissues.
- Mutations in TSP-5 cause skeletal dysplasias: pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED/EDM1).
- Affected chondrocytes exhibit enlarged rough endoplasmic reticulum (rER) cisternae filled with TSP-5 and other matrix proteins.
Purpose of the Study:
- To review and discuss in vitro and in vivo models for studying PSACH and MED.
- To describe transgenic mouse models expressing human mutant TSP-5.
- To elucidate the cellular mechanisms underlying PSACH and MED.
Main Methods:
- Review of existing in vitro and in vivo model systems.
- Generation and analysis of two transgenic mouse lines expressing human mutant TSP-5.
- Investigation of chondrocyte phenotypes and cellular pathology.
Main Results:
- Model systems revealed key features of PSACH cellular pathology.
- Observed phenomena include unfolded protein response activation.
- Upregulation of apoptosis and inappropriate matrix network assembly within the rER were noted.
Conclusions:
- In vitro and in vivo models, including transgenic mice, are valuable for studying PSACH and MED.
- These models illuminate the cellular consequences of TSP-5 mutations.
- The models may serve as tools for testing therapeutic interventions for these skeletal dysplasias.

